Cambridge Investment Research Advisors
ASPN icon

Cambridge Investment Research Advisors’s Aspen Aerogels ASPN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,792
Closed -$188K – 3508
2024
Q4 		$188K Sell
15,792
-484
-3% -$8.25K ﹤0.01% 3205
2024
Q3 		$451K Buy
16,276
+853
+6% +$21.3K ﹤0.01% 2490
2024
Q2 		$368K Buy
+15,423
New +$362K ﹤0.01% 2547
2020
Q4 		– Sell
-58,586
Closed -$642K – 2709
2020
Q3 		$642K Buy
+58,586
New +$463K ﹤0.01% 1443

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cambridge Investment Research Advisors's ASPN Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 15,792 shares — an estimated $188K sold.

Cambridge Investment Research Advisors first reported a position in ASPN in Q3 2020 and held it in 4 quarters. The position peaked at $642K in Q3 2020. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,792 Aspen Aerogels shares in Q1 2025, an estimated $188K.
  • Cambridge Investment Research Advisors first reported a position in Aspen Aerogels in Q3 2020 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Aspen Aerogels position peaked at $642K in Q3 2020.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.